More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Vaccine manufacturer employee contracts poliovirus An employee of vaccine manufacturer Bilthoven Biologicals (BBio) has been infected with a poliovirus. The virus was found in a stool sample provided by the employee. The employee concerned is now in isolation.
Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Antibiotic use and antimicrobial resistance remain stable Antibiotic resistance in the Netherlands remained stable in 2021 compared with the five previous years. This is evident from the 2022 annual NethMap/MARAN report.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
Sewage treatment workers not more likely to carry antibiotic-resistant bacteria Employees at sewage and wastewater treatment plants in the Netherlands and Germany are not more likely to carry antibiotic-resistant bacteria than other people. Unie van Waterschappen
Antimicrobial resistance in the Netherlands stable in 2020 In 2020, the year of the coronavirus SARS-CoV-2 pandemic, resistant bacteria were not found more often in patients in the Netherlands than before the outbreak.
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw